Rossella Bruno

2PUBLICATIONS
4CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 03, 2020
Crizotinib in ROS1 and MET Deregulated NSCLC-Response.

Lorenza Landi, Rossella Bruno, Gabriella Fontanini

|Aug 17, 2019
Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non-Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial.

Lorenza Landi, Rita Chiari, Marcello Tiseo

Pageof 1